These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 856532)
21. 99Tcm-labelled chimeric human/mouse anti-granulocyte antibody bone marrow scintigraphy: a preliminary clinical study. Higuchi T; Inoue T; Sarwar M; Oriuchi N; Karasawa M; Naruse T; Yamanaka H; Watanabe T; Chung JK; Endo K Nucl Med Commun; 1998 May; 19(5):463-74. PubMed ID: 9853336 [TBL] [Abstract][Full Text] [Related]
22. Bone scanning in management of metastatic osteogenic sarcoma. Siddiqui AR; Wellman HN; Weetman RM; Smith WL Clin Nucl Med; 1979 Jan; 4(1):6-11. PubMed ID: 283899 [TBL] [Abstract][Full Text] [Related]
23. Screening for bone metastases. Are only scans necessary? McDougall IR; Kriss JP JAMA; 1975 Jan; 231(1):46-50. PubMed ID: 1243567 [TBL] [Abstract][Full Text] [Related]
24. The value of bone scanning in the staging of breast cancer. Kirkman S; Henk JM Clin Radiol; 1979 Jan; 30(1):11-4. PubMed ID: 421415 [TBL] [Abstract][Full Text] [Related]
27. [Detection of bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. I. Incidence of bone metastases from bronchogenic carcinoma and their prognosis (author's transl)]. Fujimura N Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Nov; 38(11):1054-63. PubMed ID: 733476 [No Abstract] [Full Text] [Related]
28. Bone scintigraphy in plasma-cell myeloma. A prospective study of 70 patients. Bataille R; Chevalier J; Rossi M; Sany J Radiology; 1982 Dec; 145(3):801-4. PubMed ID: 6292996 [TBL] [Abstract][Full Text] [Related]
29. [Comparison between traditional skeletal radiography and total body bone scintigraphy in the diagnosis of multiple myeloma]. Scutellari PN; Spanedda R; Feggi LM; Calzolari F; Cervi PM Radiol Med; 1984 May; 70(5):271-6. PubMed ID: 6531460 [TBL] [Abstract][Full Text] [Related]
30. Skeletal scanning in neoplastic disease. O'Mara RE Cancer; 1976 Jan; 37(1 suppl):480-6. PubMed ID: 1247979 [TBL] [Abstract][Full Text] [Related]
34. [Bone metastases from breast cancer as detected by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)]. Fujimura N Nihon Igaku Hoshasen Gakkai Zasshi; 1978 May; 38(5):449-56. PubMed ID: 693261 [No Abstract] [Full Text] [Related]
35. Evaluation of radiography and isotopic scintigraphy for detecting skeletal metastases in breast cancer. Roberts JG; Gravelle IH; Baum M; Bligh AS; Leach KG; Hughes LE Lancet; 1976 Jan; 1(7953):237-9. PubMed ID: 55541 [TBL] [Abstract][Full Text] [Related]
36. [NMR tomography in plasmacytoma]. Linden A; Gückel C; Widder R; Jungehülsing M; Diehl V; Schicha H Rofo; 1992 Jan; 156(1):83-8. PubMed ID: 1733480 [TBL] [Abstract][Full Text] [Related]
37. Detection of bone metastases in urogenital malignancies utilizing 99mTc-labeled phosphate compounds. Parthasarathy KL; Landsberg R; Bakshi SP; Donoghue G; Merrin C Urology; 1978 Jan; 11(1):99-102. PubMed ID: 622775 [TBL] [Abstract][Full Text] [Related]
39. What is the significance of solitary bony abnormalities on bone scintigrams of children with malignancy? Freeman SJ; Sonoda LI; Seshadri N; Howard W; Set PA; Balan KK Pediatr Hematol Oncol; 2010 Aug; 27(5):380-6. PubMed ID: 20469974 [TBL] [Abstract][Full Text] [Related]
40. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma. Chakraborty D; Bhattacharya A; Mete UK; Mittal BR Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]